Topiramate Tablet, Film Coated
Product Images NDC 50090-7067

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50090-7067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0ed6c856 4d95 4aeb B925 15346555a2ab 565 2)

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Chemical structure of topiramate, illustrating its molecular arrangement with labeled functional groups including a sulfonamide and several oxygen-containing rings.*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
A line graph depicting cumulative rates for time to first seizure over a period of 500 days comparing two dosages of topiramate: 50 mg/day and 400 mg/day. The x-axis represents time in days, and the y-axis shows cumulative seizure rates. Two lines illustrate seizure occurrence trends for each dosage group with statistical significance indicated (p = 0.0002).*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rate between placebo and topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day across two studies. Bars represent Study 1 and Study 2 results with sample sizes indicated, showing greater reduction in migraine periods with increasing topiramate dose. Statistical significance is noted with p-values less than 0.01 and 0.001 for higher doses.*
FDA Label Image

Label Image (Lbl500907067)

Label Image (Lbl500907067)
Topiramate 25 mg film-coated tablets in a bottle label by A-S Medication Solutions. The label states each film-coated tablet contains 25 mg of topiramate, with a total of 90 tablets. It includes storage instructions to store at 68°F to 77°F and protect from moisture. The NDC is 50090-7067-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.